Flora Zarola* and Barbara Middei
Volume2-Issue3
Dates: Received: 2021-03-11 | Accepted: 2021-03-24 | Published: 2021-03-25
Pages: 213-215
Abstract
Most studies in literature about the occurrence of the so-called vascular epilepsy suggest that this complication is an episodic and relatively rare event mostly due to clinical conditions related to haemorrhagic ictus while chronic vascular disease (multifocal vascular encephalopathy, vasculopathy with lacunar infarcts or minor stroke and ischemic strokes) is not usually considered as risk factors for the onset of secondary epilepsy. Furthermore, the epilepsy of the elderly is often ascribed to the atrophy of the brain tissues linked to both age and chronic hypoxia induced by Atherosclerosis (ATS) or a complication of pharmacological therapies in the elderly (anticholinesterases, neuroleptics, anticoagulants). In fact, in our clinical and practical experience in the district outpatients clinic and home care center, numerous clinical cases have been subject to diagnosis and treatment of late epilepsy following an ischemic stroke. In this study we had thepurpose to describe our experience of occurrence of epileptic complications in patients with morewide Cerebrovascular Disease (CVD) patterns. We studied a group of 15 patients (8 Male and 7 Female) affected by CVD and by recent recently onset epilepsy. Our study found that Cerebrovascular disease CVD constitutes a significant risk factor for secondary epilepsy in the groups with elder age even though younger subjects can be involved after being affected by relevant cerebrovascular events. In opposition to the opinion assumed in common clinical practice an important part of these causal events are ischemic and non-haemorrhagic as previously known.
FullText HTML
FullText PDF
DOI: 10.37871/jbres1213
Certificate of Publication
Copyright
© 2021 Zarola F, et al. Distributed under Creative Commons CC-BY 4.0 
How to cite this article
Zarola F, Middei B. Occurrence of Epileptic Complications in Patients with Cerebrovascular Disease in Charge to the Home Care Center: A Clinical Experience. J Biomed Res Environ Sci. 2021 Mar 25; 2(3): 213-215. doi: 10.37871/jbres1213, Article ID: jbres1213
Subject area(s)
References
- Zhao Y, Li X, Zhang K, Tong T, Cui R. The Progress of Epilepsy after Stroke. Curr Neuropharmacol. 2018;16(1):71-78. doi: 10.2174/1570159X15666170613083253. PMID: 28606039; PMCID: PMC5771387.
- Yang H, Rajah G, Guo A, Wang Y, Wang Q. Pathogenesis of epileptic seizures and epilepsy after stroke. Neurol Res. 2018 Jun;40(6):426-432. doi: 10.1080/01616412.2018.1455014. Epub 2018 Apr 21. PMID: 29681214.
- Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshé SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):512-521. doi: 10.1111/epi.13709. Epub 2017 Mar 8. PMID: 28276062; PMCID: PMC5386840.
- Zarola F. Efficacy of Lacosamide on an aged patient with behavioural impairment consisting in impulse dyscontrol, aggressiveness and insomnia. J Neurosci Neurosurg. 2019 Nov;2(4);139.
